StonvexLoading…
StonvexStonvexStonvexCore line items from LEVI's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-11-30 | Annual 2024 2024-12-01 | Annual 2023 2023-11-26 | Annual 2022 2022-11-27 |
|---|---|---|---|---|
Revenue | $6.28B | $6.03B | $5.84B | $6.17B |
Operating Income | $677.60M | $262.70M | $354.40M | $646.50M |
Net Income | $578.10M | $210.60M | $249.60M | $569.10M |
EPS (Diluted) | $1.45 | $0.52 | $0.62 | $1.41 |
Total Assets | $6.85B | $6.38B | $6.05B | $6.04B |
Total Liabilities | $4.57B | $4.41B | $4.01B | $4.13B |
Cash & Equivalents | $757.90M | $690.00M | $398.80M | $429.60M |
Free Cash Flow OCF − CapEx | $308.20M | $670.90M | $121.90M | $-39.00M |
Shares Outstanding | 399.75M | 402.37M | 401.72M | 403.84M |